Member Info for InContext

Its worth looking at ADOR website which has been updated.
http://www.adordx.com
ADOR are with Adaltis at Medica Nov 14th to 17th.
New diagnostics platform employing RCA. Rolling Circle Amplification is close to market.
Now is not the time to sell IMO

BATM got clobbered on the misconception it was a Covid Company so when the demand for tests fell away then the company SP got slammed. Less obvious is the fact that the Bio Med non covid business grew where by the end of this year it will have made up for the Covid tests losses. BATM actually saw growth in the first half of 2022 in all divisions and they made a profit. >nutmeg.. if you know how this was done we are all ears. It is massively oversold and completely miscategorised.

Ordinary ShareSymbol : BVCDL
Dual-Listed Company
Last Rate (0.01 NIS)
131.8C
Closing Price
Change
7.18% Down
Turnover
39,533,998 NIS
Base:
142
Open:
142
High:
144.8
Low:
131.8 As of 04/08/2022 17:35 15 min delay

Someone agrees with you Nutmeg.

https://www.ii.co.uk/analysis-commentary/12-stock-ideas-brave-bargain-hunters-ii524783?utm_source=newsletter&utm_medium=email&utm_campaign=NEW-DLY-ENGAGE-afternoon_round_up_270722%20(1)&utm_content=newsletter&spMailingID=20555268&spUserID=MTM4NzM1NDAwNjAxS0&spJobID=2038297133&spReportId=MjAzODI5NzEzMwS2

Very High volumes again today on TASE and LSE. Something has got to give here.

Volumes were high on TASE and LSE. Weakness has started on TASE for months now and then got walked down on LSE with very low volumes and no one wanting to catch the proverbial falling knife. BATM is well funded, profitable with some soon to be exploited valuable IP. FMV for BATM likely around the 80p mark so they have a lot of daylight above them.

Its true that Edgility revenue will start as a trickle which its already doing. As the use of Edge computing and virtual networks expands Telco Systems gain from new clients but they should retain a large part of existing clients so its a cumulative revenue flow. Company has plenty of cash in the bank, makes a profit and pays for the development of its IP in house with no dilution to shareholders. When assessing what BATM actually makes yearly if you add the existing profit to their R&D costs it makes a large difference when comparing many companies who do not have large R&D budgets.

BATM partners with CityFibre for Edgility

The UK's largest independent carrier-neutral Full Fibre platform selects the Group's virtual network and edge compute solution

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that CityFibre, the UK's largest independent carrier-neutral Full Fibre platform, has selected BATM's Edgility virtual networking and edge compute solution. Following extensive lab testing, CityFibre will now be piloting the Edgility platform with selected partners ahead of an expected national deployment to provide virtualised network services for businesses.

Posted over on ADVFN.

https://aitrends.vision/news/trending-news/nexcom-and-telco-systems-launch-pre-installed-5g-iot-solutions-for-virtual-edge-service-management/

Certainly not the time to bail. SP over corrected by a country mile due to unrelated string of events that have nothing to do with the profitability of the company. Share buy back was held up due to the company sitting on materially good or bad news. They have just published a stunning set of results and there is no profits warning so probably a large tie up for Ador or Telco or another cyber contract. Take your pick.

Dartron whilst you are entitled to your point of view your hypothesis is absurd and certainly not factual.
Please try to to do better or report to the headmaster's office.

https://ca.proactiveinvestors.com/companies/news/975263/batm-advanced-communications-reflect-on-a-great-year-in-2021-975263.html

You have to ask yourself what changed in 3 months. 2021 was a pivotal year for BATM and forward looking statements are excellent. The company has a FMV @ 80p on almost any metric on pure revenue let alone what the IP is worth.

Dartron there is a decent interview with Zvi @ 3months ago and a recent published set of results.
Agree with your frustration but there are items to consider.... Israeli Tech stocks are badly oversold in general. Diagnostics companies have been hit on all the exchanges, there was the Russell index nonsense, oh and we have a war as well and a recession. There are also restrictions on Company buy backs with respect to conflicts with internal news that could have an effect on the SP if its not in the public domaine. Still the SP has been slammed.

The share price has slid and now completely collapsed against a background of very encouraging published results and excellent forward guidance. The volumes have been very low and the total amount of shares traded in the last 6 months does not amount to much. At these levels some company could take them over for spare change something has to give here because it can not continue like this for much longer.

It's a very comprehensive report and should be read carefully by investors. The only downsides are the Russel Index fiasco which has been interpreted incorrectly and does not amount to a bag of beans in any event and has no effect on the company just an unwanted distraction. Other concern is an increasing backlog of orders due to chip shortages and pandemic restrictions to travel which I can concur has made it tough to get people on site where necessary. Solid year end with a very firm outlook for this year. Company is wildly undervalued.

Yes thats a distinct possibility as they have been held back with pandemic restrictions in getting technicians on site.
Quite often if they are twittering about something we end up getting a RNS.... "quite" being the operative word.
The agricultural shredders and protein by product is a win win ....

In a recent interview Marom said he expected this sector to be very robust and they intended to build up this side of the business and then sell off the Government and defence business and retain the rest of it. Its bundled into Edgility for example.

Its at their discretion and i am sure they wont telegraph this otherwise it will spike the price which I understand there are rules in effect to prevent this from happening. By any metrics known to investing these shares are trading at half price.

BATM passed a resolution to buy back up to 10% of the company's shares. There is no time frame for this and there are constraints in company buy backs to not cause an artificial spike in the SP.
BATM have a FMV of @80p based on pure fundamentals without looking at their growth and value of the IP.
Thats based on comparison with their peers. Thats why they had support for so long at those levels.

The only effect this would have on BATM is the same as it is for any company that uses chips. BATM are primarily focussed on developing IP and achieving subscription revenue from cyber and NFV. They do make some physical hardware ie. UCPE white boxes but expanding manufacturing is not their thing. That said anything that extends the chip shortage will spook investors. Hopefully they will get that sick weasel out of Russia and the Ukraine, he's not well and thats scary.